InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Artikelnummer | A24 |
Tidsskrift | American Journal of Respiratory and Critical Care Medicine |
Vol/bind | 199 |
Udgave nummer | A1116 |
ISSN | 1073-449X |
Status | Udgivet - 2019 |
Links
- https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1116
Forlagets udgivne version
ID: 218435775